Spotlight: Renal mechanisms in the management of diabetes - SGLT2 Inihibitors

A new treatment frontier

To date, management of diabetes has focussed on enhanced insulin secretion or sensitivity to the hormone. An emerging strategy enhances renal elimination of glucose from the body by blocking the SGLT2 transporter. This spotlight of UEndcorine's Ask the Expert addresses questions related the SGLT2 inhibitors, an emerging treatment option.

Dr. Jordan Weinstein
Nephrologist, St. Michael's Hospital
Assistant Professor of Medicine, University of Toronto